What is the typical dosage of Berodual (ipratropium bromide and fenoterol) in puffs?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Berodual 20/50 mcg Dosing

Berodual 20/50 mcg (ipratropium 20 mcg/fenoterol 50 mcg per puff) is typically dosed at 2 puffs four times daily for chronic maintenance therapy, or 2 puffs every 20 minutes for 3 doses during acute exacerbations. 1, 2

Standard Maintenance Dosing

  • For stable asthma or COPD, administer 2 puffs four times daily (4 x 2 puffs/day), delivering a total daily dose of 160 mcg ipratropium and 400 mcg fenoterol 1, 2
  • This regimen provides consistent bronchodilation throughout the day without tachyphylaxis 1
  • The combination achieves equivalent efficacy to higher-dose beta-agonist monotherapy while using less beta-2-agonist, potentially reducing tremor and cardiovascular side effects 1

Acute Exacerbation Dosing

  • During acute exacerbations, use 2 puffs every 20 minutes for 3 doses, then transition to every 2-4 hours as needed 3, 4
  • This aggressive initial dosing (similar to standard ipratropium/albuterol protocols) should always be combined with systemic corticosteroids for moderate-to-severe exacerbations 3
  • After the first hour of intensive treatment, reassess response and space dosing intervals based on clinical improvement 3, 4

Critical Administration Details

  • Always use a spacer device (valved holding chamber) with the MDI for optimal drug delivery, as this technique is as effective as nebulized therapy when administered correctly 3, 4
  • For children under 4 years, a spacer with face mask is mandatory 3, 5
  • Each actuation must be coordinated with inspiration for maximal lower airway deposition 6

Comparison with Alternative Formulations

  • Berodual 20/50 provides equivalent bronchodilation to the higher-dose Duovent formulation (ipratropium 40 mcg/fenoterol 100 mcg) when used at 2 puffs four times daily, with no demonstrable difference in peak flow values 2
  • The Respimat Soft Mist Inhaler formulation allows for even lower nominal doses while maintaining therapeutic equivalence 7

Common Pitfall to Avoid

  • Do not use Berodual as monotherapy during acute exacerbations—the anticholinergic component (ipratropium) should be viewed as adjunctive therapy to the beta-agonist (fenoterol), and systemic corticosteroids are essential for moderate-to-severe presentations 3, 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.